We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > violations

News List

Federal Judge Enters Consent Decree against Pharmedium for Violations at Multiple Facilities americanpharmaceuticalreview
May 24, 2019
U.S. District Judge Virginia M. Kendall for the Northern District of Illinois entered a consent decree of permanent injunction today between the United States and PharMedium Services, LLC, headquartered in Lake Forest, Ill., as well as ...
ANDAPharm repeat violations lead to FDA action fiercepharma
March 08, 2019
The FDA has issued a warning letter to a Florida CMO that it says has dirty equipment, poor storage methods and questionable record keeping about whether drugs were effective.
Dr. Reddy's racks up more repeat violations at Bachupally formulations plant fiercepharma
February 24, 2019
Dr. Reddy’s, which has been struggling to bring a number of its key plants up to FDA standards, has been unable to learn from past mistakes, including at its formulations plant in Bachupally.
Aegerion pleads guilty to US marketing violations pharmatimes
September 26, 2017
Aegerion Pharmaceuticals will pay $40.1 million to resolve US investigations into marketing and sales of its cholesterol drug Juxtapid, authorities said on Friday.